Schedule 13G ownership disclosure

Relay Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 75943R102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CASDIN CAPITAL, LLC

    Shares: 13,003,574.00 · Class: 7.5%

  • CASDIN PARTNERS MASTER FUND, L.P.

    Shares: 12,585,000.00 · Class: 7.3%

  • CASDIN PARTNERS GP, LLC

    Shares: 13,003,574.00 · Class: 7.5%

  • ELI CASDIN

    Shares: 13,003,574.00 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-001221
Form type
SCHEDULE 13G/A
Filer
Casdin Capital, LLC
CIK
CIK 1534261
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub